Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1 Receptor Agonists or Dual GLP-1/GIP Receptor Agonists vs. SGLT2 Inhibitors in Patients with Atrial Fibrillation and HFpEF: A Propensity-Matched Real-World Analysis.

Journal of clinical medicine·2026
Same author

Investigating the attitudes and perceived drivers of research engagement among academicians of private dental colleges of Lahore, Pakistan.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Characterization of microbiome diversity and its association with healing outcomes in diabetic foot ulcer patients.

Scientific reports·2026
Same author

Efficacy and safety of lorecivivint for the treatment of knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials.

Journal of orthopaedic surgery (Hong Kong)·2026
Same author

Antibiofilm efficacy and genomic characterization of a lytic bacteriophage targeting MDR uropathogenic Escherichia coli.

Archives of microbiology·2026
Same author

Nationwide trends and forecasts in Alzheimer's and cerebrovascular disease-related mortality in the United States, 1999-2023: A CDC WONDER analysis.

The Journal of international medical research·2026

Related Experiment Video

Updated: Jul 16, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K

Management and Outcomes of Bilateral Simultaneous Rhegmatogenous Retinal Detachments.

Omar B Saeed1, Muhammad Hassan2,3, Dan M Miller2,3

  • 1Kettering Health Dayton, Dayton, OH, USA.

Journal of Vitreoretinal Diseases
|December 29, 2025
PubMed
Summary

Managing bilateral simultaneous rhegmatogenous retinal detachment (RRD) requires considering symptom duration and chronicity, not just macular status. Prioritizing acute presentations may improve visual outcomes in RRD patients.

Keywords:
Bilateral retinal detachmentmacularhegmatogenous retinal detachmentscleral bucklevitrectomy

More Related Videos

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.3K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

933

Related Experiment Videos

Last Updated: Jul 16, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.4K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.3K
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats
04:16

Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats

Published on: March 7, 2025

933

Area of Science:

  • Ophthalmology
  • Retinal Surgery

Background:

  • Bilateral simultaneous rhegmatogenous retinal detachment (RRD) presents unique management challenges.
  • Current surgical timing and sequencing often rely heavily on macular status.

Purpose of the Study:

  • To evaluate a modified approach for managing bilateral simultaneous RRD.
  • To guide surgical timing and sequencing based on factors beyond macular status.

Main Methods:

  • Retrospective review of 47 patients with bilateral simultaneous RRD.
  • Patients grouped by macular status: both attached (AA), both detached (DD), or one attached/one detached (DA).
  • Cohort DA further divided based on surgical order: detached eye first (3D) or attached eye first (3A).

Main Results:

  • No significant difference in visual acuity (VA) between first and second eyes in AA and DD cohorts.
  • In DA cohort, operating on the macula-detached eye first yielded significantly better visual outcomes (0.5 vs 0.9, P=.03).
  • First-operated eyes often showed more symptoms, fewer signs of chronicity, or larger detachments.

Conclusions:

  • Bilateral simultaneous RRD frequently exhibits chronic features.
  • Surgical decisions for RRD should incorporate symptom duration and clinical indicators of chronicity.
  • Prioritizing eyes with acute presentations may enhance visual outcomes in RRD management.